Browse by People

Collapse authors list.
Wilding, John ORCID: 0000-0003-2839-8404, Fernando, Kevin, Milne, Nicola, Evans, Marc, Ali, Amar, Bain, Steve, Hicks, Debbie, James, June, Newland-Jones, Philip, Patel, Dipesh et al (show 1 more authors) and Viljoen, Adie (2018) SGLT2 Inhibitors in Type 2 Diabetes Management: Key Evidence and Implications for Clinical Practice. DIABETES THERAPY, 9 (5). 1757 - 1773.

Collapse authors list.
Ali, Amar, Bain, Steve, Hicks, Debbie, Jones, Phillip Newland, Patel, Dipesh C, Evans, Marc, Fernando, Kevin, James, June, Milne, Nicola, Viljoen, Adie et al (show 2 more authors) , Wilding, John ORCID: 0000-0003-2839-8404 and Comm, Improving Diabet Steering (2019) SGLT2 Inhibitors: Cardiovascular Benefits Beyond HbA1c-Translating Evidence into Practice. DIABETES THERAPY, 10 (5). 1595 - 1622.

Collapse authors list.
Wheeler, David C, James, June, Patel, Dipesh, Viljoen, Adie, Ali, Amar, Evans, Marc, Fernando, Kevin, Hicks, Debbie, Milne, Nicola, Newland-Jones, Philip et al (show 2 more authors) , Wilding, John ORCID: 0000-0003-2839-8404 and as part of the Improving Diabetes Steering Committee, (2020) SGLT2 Inhibitors: Slowing of Chronic Kidney Disease Progression in Type 2 Diabetes. Diabetes therapy : research, treatment and education of diabetes and related disorders, 11 (12). 2757 - 2774.